Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Non-Current Deffered Revenue (2017 - 2021)

Solid Biosciences (SLDB) has disclosed Non-Current Deffered Revenue for 3 consecutive years, with $2.3 million as the latest value for Q3 2021.

  • Quarterly Non-Current Deffered Revenue changed N/A to $2.3 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Sep 2021, changed N/A year-over-year, with the annual reading at $10.4 million for FY2020, N/A changed from the prior year.
  • Non-Current Deffered Revenue hit $2.3 million in Q3 2021 for Solid Biosciences, down from $4.3 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $10.4 million in Q4 2020 to a low of $2.3 million in Q3 2021.
  • Historically, Non-Current Deffered Revenue has averaged $5.4 million across 3 years, with a median of $4.3 million in 2021.